(Press-News.org) The Icahn School of Medicine at Mount Sinai announced today the launch of a new center for “Research on Emerging Substances, Poisoning, and Overdose, for New Discoveries,” to be known as the RESPOND Center. Its research findings could lead to major advances in this area of medicine, including better treatments for patients with drug overdoses in emergency departments across the United States.
“Each day, clinicians on the front lines bear witness to devastating impacts from the current epidemic of substance use and illicit opioid overdose, not just to individuals, but to their families and communities. RESPOND Center researchers are making significant contributions to the field by focusing on the identification of emerging substances, the treatment of addiction as well as nonfatal overdose, and the prevention of adverse events to our patients,” says Alex Manini, MD, MS, the Director of the RESPOND Center, and a Professor of Emergency Medicine at the Icahn School of Medicine at Mount Sinai.
“Research is a team sport, and the RESPOND Center focuses on multidisciplinary approaches to problem-solving, bringing together experts from various fields, including toxicology, addiction, psychiatry, pharmacology, emergency medicine, and public health,” Dr. Manini adds. “Through important collaborations with the American College of Medical Toxicology, the Centers for Forensic Science Research Education, the National Institutes of Health, and the Centers for Disease Control and Prevention, among others, we hope our efforts will result in a significant reduction in overdose-related deaths in the United States.”
More than 100,000 people in the United States died from drug-involved overdoses in 2021, the majority from opioid drugs. In 2022, 3,026 New Yorkers died of a drug overdose, a 12 percent increase from 2021 and the highest number since reporting began in 2000. Fentanyl is one of those deadly opioids, and 25 percent of the fentanyl supply includes xylazine, an animal sedative. This has become a recent, growing threat that is leading to increased rates of addiction and adverse events such as severe skin lesions, hypothermia, and heart and respiratory issues. A subclass of opioid drugs called nitazenes are now emerging in the illicit opioid supply in the United States and are even more potent than fentanyl. According to a recent study in JAMA led by Dr. Manini, nitazenes add a layer of complexity to the dangers of illicit drug use, leading to a significantly increased rate of cardiac arrest in overdose cases and requiring significantly higher doses of naloxone for in-hospital treatment when compared to fentanyl overdoses. The RESPOND Center will prioritize researching these new threats.
This new center will conduct clinical research on a wide range of topics focused on opioids, synthetic opioids, hallucinogens, stimulant drugs including cocaine and methamphetamines, emerging drugs, and health services. Researchers will collect and analyze data from patients across emergency departments within the Mount Sinai Health System to advance knowledge and understanding of overdose, poisonings, and substance use disorders and discover new treatments.
Researchers from the RESPOND Center will draw from $14 million in grants from various institutions including the National Institute on Drug Abuse; the National Heart, Lung and Blood Institute; and the National Institute of Mental Health to study non-deadly drug overdose, fentanyl analogues, opioid use disorders, and emergency room patient management. The work of the RESPOND Center also involves collaboration between Mount Sinai’s Department of Emergency Medicine, the Medical Toxicology Division, the Addiction Institute of Mount Sinai, and the American College of Medical Toxicology.
“Through this center, we hope to establish best practices for addressing the needs of patients who are exposed to the continuous flow of new drugs of abuse. We aim to define the unique risks of each of these substances and develop and deploy programs to mitigate these risks in a way that keeps people safe and alive,” says Ethan Cowan, MD, Professor of Emergency Medicine at Icahn Mount Sinai. “Given the severity of the overdose epidemic, this work will be critical to stemming the flow of opioid overdose deaths. The center will also offer mentorship and training for a new generation of emergency medicine researchers who have a passion for improving the care and treatment for our most vulnerable patient populations.”
For more information on the RESPOND Center click on the link below:
https://icahn.mssm.edu/about/departments/emergency-medicine/research/respond-center
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, more than 400 outpatient practices, more than 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it. Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2023-2024.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
END
Mount Sinai creates research center focusing on opioids, emerging substances, and drug overdose
2023-11-28
ELSE PRESS RELEASES FROM THIS DATE:
Soccer heading linked to measurable decline in brain function
2023-11-28
CHICAGO – New research being presented this week at the annual meeting of the Radiological Society of North America (RSNA) links soccer heading – where players hit the ball with their head – to a measurable decline in the microstructure and function of the brain over a two-year period.
“There is enormous worldwide concern for brain injury in general and in the potential for soccer heading to cause long-term adverse brain effects in particular,” said senior author Michael L. Lipton, M.D., Ph.D., professor of radiology at Columbia University’s Vagelos College of Physicians and Surgeons and affiliate professor of ...
Marijuana, cigarette smokers at increased risk of emphysema
2023-11-28
CHICAGO – Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs, according to research being presented today at the annual meeting of the Radiological Society of North America (RSNA).
It is commonly believed that smoking marijuana is not harmful to the lungs. There is an abundance of established research that identifies the harms of cigarette smoking. In contrast, very little is known about the effects of marijuana smoking, and even less research has been done on the combined effects of smoking marijuana and cigarettes.
“Marijuana is the most widely used illicit psychoactive ...
New strategies generate more accurate pediatric brain organoids
2023-11-28
Essential features of the cortex, an important part of the human brain and its development, are more accurately captured in organoids generated by researchers of the Princess Máxima Center for pediatric oncology and the Hubrecht Institute. The scientists developed mini-organs with features like cell organization, stem cell expansion and cell identity that more closely mimic the real-life situation. These novel organoids can be used as a basis to model pediatric brain tumors.
Multiple childhood brain tumors, like cortical gliomas, arise from the cortex, the outer layer of the largest part of the brain and the brain’s ...
Commitments needed to solve aviation’s impact on our climate, says new research
2023-11-28
Concerted efforts and commitments are needed to solve the complex trade-offs involved in reducing the impact of aviation on the climate, according to new research.
Non-CO2 emissions from aircraft - largely of nitrogen oxides, soot and water vapour – are known to add to global warming effects alongside the aviation sector’s other CO2 emissions.
Soot triggers the formation of contrails and ‘contrail cirrus’, which are line-shaped clouds produced by aircraft engine exhaust. This causes an increase in high clouds that can warm the Earth’s atmosphere.
In a comprehensive assessment ...
Critical care of patients after cardiac arrest is crucial, needs more research
2023-11-28
Statement Highlights:
Intensive care management of cardiac arrest survivors is important and influences survival and neurological outcomes.
This collaborative statement from a diverse group with expertise in post-cardiac arrest care identifies current knowledge gaps and provides guidance about care in topics where research and existing guidelines were not able to provide solid evidence.
This statement calls for more research into neurological, cardiac, pulmonary, hematologic, infectious, gastrointestinal, endocrine and general critical care management after cardiac arrest.
Embargoed until 4 a.m. CT / 5 a.m. ET Tuesday, ...
Proposals for an efficient and effective corporate sustainability due diligence in Europe
2023-11-28
The Supply Chain Intelligence Institute Austria (ASCII) advocates for a revision of the EU Corporate Sustainable Due Diligence Directive (CS3D). The proposed amendments focus on direct monitoring of suppliers – instead of bilateral supply links – and the introduction of negative and positive lists to streamline due diligence processes, improving effectiveness and reducing costs for EU importers.
The Corporate Sustainability Due Diligence Directive (CS3D), currently under negotiation by EU institutions with a potential adoption in 2024, aligns with international norms to cover both human rights and environmental ...
IOP Publishing launches Sustainability Science and Technology – a new interdisciplinary OA journal aimed at fostering a sustainable future
2023-11-28
IOP Publishing (IOPP) is launching Sustainability Science and Technology, an interdisciplinary, open access journal dedicated to advancing sustainability through cutting-edge research in science, technology, and engineering. The new journal will bring together researchers from diverse disciplines across engineering, chemistry, physics, materials science and environmental science to address global challenges and contribute to a more sustainable future.
Sustainability Science and Technology sets itself apart by focussing on the critical importance of sustainable impact. ...
Female toxin-producing newts are surprisingly more poisonous than males
2023-11-28
Tetrodotoxin, the neurotoxin that makes a blue-ringed octopus deadly, also protects Taricha newts — but we don’t understand how they produce it, or what purposes it serves for them. A first step to answering these questions is understanding whether different levels appear in males and females. In sexually reproducing animals, dimorphic traits such as color or canine tooth size can be key for survival and reproductive fitness. Investigating whether toxin production is a sexually dimorphic trait in newts gets us closer to understanding it.
“It had long been considered that newts’ ...
Macaque trials offer hope in pneumonia vaccine development
2023-11-28
Osaka, Japan – The global impact of the coronavirus pandemic has ignited a renewed focus on emerging and re-emerging infectious diseases. Researchers at Osaka Metropolitan University are making great strides in combating pneumococcal pneumonia, one of the leading causes of respiratory deaths worldwide.
Despite the existence of vaccines against pneumococcal infections such as otitis media, sinusitis, and meningitis, the prevalence of pneumococcal pneumonia remains high. Currently, around 100 new serotypes of Streptococcus pneumoniae have been identified, and ...
Nextgen computing: Hard-to-move quasiparticles glide up pyramid edges
2023-11-28
Image
A new kind of "wire" for moving excitons, developed at the University of Michigan, could help enable a new class of devices, perhaps including room temperature quantum computers.
What's more, the team observed a dramatic violation of Einstein's relation, used to describe how particles spread out in space, and leveraged it to move excitons in much smaller packages than previously possible.
"Nature uses excitons in photosynthesis. We use excitons in OLED displays and some LEDs and solar cells," said Parag Deotare, ...